Stocksigma LogoStocksigma Logo

Ajooni Biotech Q1FY27: Revenue Doubles but Profit Declines

Ajooni Biotech reported a mixed performance for Q1 ended 30-Jun'26. Revenue from operations doubled to ₹6,349.07 lakh, a 103.1% YoY increase from ₹3,126.77

Ajooni Biotech Q1FY27: Revenue Doubles but Profit Declines

Ajooni Biotech Ltd · Outcome · 14 Aug 2026, 10:52 pm

Ajooni Biotech Q1FY27: Revenue Doubles but Profit Declines Ajooni Biotech reported a mixed performance for Q1 ended 30-Jun'26. Revenue from operations doubled to ₹6,349.07 lakh, a 103.1% YoY increase from ₹3,126.77 lakh. However, Net Profit declined by 44.7% YoY to ₹43.18 lakh from ₹78.14 lakh in the prior year's quarter. Sequentially, revenue grew 4.7% while profit fell sharply by 54.4%. The profit decline was driven by significantly higher material costs, which rose 112.7% YoY, and a 469% YoY surge in finance costs, compressing margins despite the strong top-line growth.

Original exchange filing (PDF)

More announcements from Ajooni Biotech Ltd

All Ajooni Biotech Ltd announcements